A new disease: Bicuspid aortic valve aortopathy syndrome

American Journal of Medicine

Volumn 125, Issue 4, 2012, Pages 322-323

  Sorrell, Vincent L ^a   Pancyzk, Eliza ^b   Alpert, Joseph S ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA DISEASE; BICUSPID AORTIC VALVE; BISCUSPID AORTIC VALVE AORTOPATHY SYNDROME; EDITORIAL; HUMAN; MARFAN SYNDROME; NOMENCLATURE; PRIORITY JOURNAL; SYNDROME DELINEATION;

AORTIC ANEURYSM; AORTIC VALVE; HUMANS; MALE;

EID: 84858991643     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.11.003     Document Type: Editorial

References (11)

1. Roberts WC. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol. 1970;26:72-83.
2. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111:920-925. (Pubitemid 40279895)
3. Nistri S, Sorbo MD, Marin M, Palisi M, Scognamiglio R, Thiene G. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart. 1999;82:19-22. (Pubitemid 29309229)
4. Bonow RO, Carabello B, de Leon AC Jr, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1-148.
5. Yasuda H, Nakatani S, Stugaard M, et al. Failure to prevent progressive dilation of aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve. Circulation. 2003;108(Suppl 1):291-294.
6. Ferencik M, Pape LA. Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves. Am J Cardiol. 2003;92:43-46. (Pubitemid 36782307)
7. Plaisance BR, Winkler MA, Attili AK, Sorrel VL. Congential bicuspid aortic valve first presenting as an aortic aneurysm. Am J Med. 2012; 125:e5-e7.
8. Daugherty A, Rateri DL, Charo IF, Owens AP, Howatt DA, Cassis LA. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin Sci (Lond). 2010;118:681-689.
9. Pannu H, Tran-Fadulu V, Milewicz DM. Genetic basis of thoracic aortic aneurysms and aortic dissections. Am J Med Genet C Semin Med Genet. 2005;139:10-16. (Pubitemid 41739242)
10. Habashi, JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117-121.
11. Larco RV, Dietz HC, Wruck LM, et al. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am Heart J. 2007;154:624-631. (Pubitemid 47429596)